Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.

Our purpose was to identify clinical, radiological and physiological (CRP) determinants of survival and to develop a CRP scoring system that predicts survival in newly diagnosed cases of idiopathic pulmonary fibrosis (IPF). The study population consisted of 238 patients with biopsy confirmed usual interstitial pneumonia. For each patient, clinical manifestations, chest radiographs, and pulmonary physiology were prospectively assessed. We used Cox proportional-hazards models to assess the effect of these parameters on survival. The effects of age and smoking were included in the analysis. Survival was related to age, smoking status (longer in current smokers), clubbing, the extent of interstitial opacities and presence of pulmonary hypertension on the chest radiograph, reduced lung volume, and abnormal gas exchange during maximal exercise. A mathematical CRP score for predicting survival was derived from these parameters. We showed that this CRP score correlated with the extent and severity of the important histopathologic features of IPF, i.e., fibrosis, cellularity, the granulation/connective tissue deposition, and the total pathologic derangement. Using these models, clinicians are in a better position to provide prognostic information to patients with IPF and to improve the selection of the most appropriate patients for lung transplantation or other standard or novel therapeutic interventions.

[1]  A. Nicholson,et al.  A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. , 1999, American journal of respiratory and critical care medicine.

[2]  T. Colby,et al.  Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. , 1998, The European respiratory journal.

[3]  J. Myers,et al.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.

[4]  R. Novick,et al.  Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease , 1998, The Lancet.

[5]  K P Offord,et al.  Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.

[6]  J A Waldron,et al.  Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. , 1997, American journal of respiratory and critical care medicine.

[7]  I. D. Johnston,et al.  British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. , 1997, Thorax.

[8]  D. Romberger,et al.  Cigarette smoke inhibits lung fibroblast proliferation and chemotaxis. , 1995, American journal of respiratory and critical care medicine.

[9]  D. Schwartz,et al.  Determinants of survival in idiopathic pulmonary fibrosis. , 1994, American journal of respiratory and critical care medicine.

[10]  N L Müller,et al.  Fibrosing alveolitis: chest radiography and CT as predictors of clinical and functional impairment at follow-up in 26 patients. , 1992, Radiology.

[11]  M. Schwarz,et al.  The impact of smoking on mechanical properties of the lungs in idiopathic pulmonary fibrosis and sarcoidosis. , 1991, The American review of respiratory disease.

[12]  H. Colebatch,et al.  Decreased pulmonary distensibility in fibrosing alveolitis and its relation to decreased lung volume. , 1989, Thorax.

[13]  M. Schwarz,et al.  A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. , 1986, The American review of respiratory disease.

[14]  E. Taskinen,et al.  Prognosis of cryptogenic fibrosing alveolitis. , 1983, Thorax.

[15]  B. Burrows,et al.  Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival , 1980, Thorax.

[16]  B. Burrows,et al.  Cryptogenic fibrosing alveolitis: clinical features and their influence on survival , 1980, Thorax.

[17]  R G Gupta,et al.  Natural history and treated course of usual and desquamative interstitial pneumonia. , 1978, The New England journal of medicine.

[18]  N. Pride,et al.  Lung distensibility. The static pressure-volume curve of the lungs and its use in clinical assessment. , 1976, British journal of diseases of the chest.

[19]  R. Forster,et al.  A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. , 1957, The Journal of clinical investigation.

[20]  J. H. Comroe,et al.  A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease. , 1956, The Journal of clinical investigation.

[21]  R. Riley,et al.  Ideal alveolar air and the analysis of ventilation-perfusion relationships in the lungs. , 1949, Journal of applied physiology.